(CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)

PHASE3CompletedINTERVENTIONAL
Enrollment

288

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Asthma
Interventions
DRUG

Beclomethasone dipropionate

Beclomethasone dipropionate HFA (QVAR® 40 mcg Inhalation Aerosol) one puff bid

DRUG

Beclomethasone dipropionate

Beclomethasone dipropionate HFA (QVAR® 40 mcg Inhalation Aerosol) rescue puffs as needed

DRUG

Albuterol sulfate

Albuterol sulfate HFA (ProAir® 90 mcg Inhalation Aerosol) rescue puffs as needed

Trial Locations (6)

63110

Washington University School of Medicine, St Louis

80206

National Jewish Medical and Research Center, Denver

85724

University of Arizona College of Medicine, Tucson

90027

Los Angeles, Kaiser Permanente Allergy Department, Los Angeles

92111

Kaiser Permanente Medical Center, San Diego

53792-3244

University of Wisconsin - Madison, Madison

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Milton S. Hershey Medical Center

OTHER

NCT00394329 - (CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA) | Biotech Hunter | Biotech Hunter